At Pint Pharma, we strive to make the lives of Latin American patients with rare diseases better by providing prompt and reliable access to cutting-edge therapies. We source innovative patent-protected biotechnologies with the potential to transform patient outcomes in areas of significant unmet need, and make them available region wide through our comprehensive and robust commercialization platform. Today, we count with nearly 250 ambitious individuals and 8 offices around the globe including: Austria (HQ), Argentina, Brazil, Chile, Colombia, Ecuador, Mexico and Peru.